Search Results - Peter E. Westerweel

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Protective Actions of PPAR-γ Activation in Renal Endothelium by Peter E. Westerweel, Marianne C. Verhaar

    Published in PPAR Research (2008-01-01)
    Get full text
    Article


  2. 2

    Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice by Camille C.B. Kockerols, Peter J.M. Valk, Mark-David Levin, Niels Pallisgaard, Jan J. Cornelissen, Peter E. Westerweel

    Published in HemaSphere (2020-12-01)
    Get full text
    Article


  3. 3

    Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. by Peter E Westerweel, Martin Teraa, Shahin Rafii, Janneke E Jaspers, Ian A White, Andrea T Hooper, Pieter A Doevendans, Marianne C Verhaar

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  4. 4

    Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study by Chantal Visser, Marieke J. H. A. Kruip, Janet Brantsma-Van der Graaf, Eric E. van Thiel, Mark-David Levin, Peter E. Westerweel

    Published in TH Open (2023-07-01)
    Get full text
    Article


  5. 5

    The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era by Camille C.B. Kockerols, Inge Geelen, Mark-David Levin, Jeroen J.W.M. Janssen, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2022-03-01)
    Get full text
    Article


  6. 6

    Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients by Paul J. Hengeveld, Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, Anton W. Langerak

    Published in Blood Cancer Journal (2025-01-01)
    Get full text
    Article


  7. 7

    Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia by Inge G.P. Geelen, Noortje Thielen, Jeroen J.W.M. Janssen, Mels Hoogendoorn, Tanja J.A. Roosma, Sten P. Willemsen, Otto Visser, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2017-11-01)
    Get full text
    Article


  8. 8

    High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population by Camille C.B. Kockerols, Inge G.P. Geelen, Mark-David Levin, Jeroen J.W.M. Janssen, H. Berna Beveloo, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2023-03-01)
    Get full text
    Article


  9. 9

    Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival by Inge G.P. Geelen, Noortje Thielen, Jeroen J.W.M. Janssen, Mels Hoogendoorn, Tanja J.A. Roosma, Sten P. Willemsen, Peter J.M. Valk, Otto Visser, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2017-12-01)
    Get full text
    Article


  10. 10

    Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate by Roisin Bavalia, Rahat Abdoellakhan, Herm Jan M. Brinkman, Marjolein P. A. Brekelmans, Eva N. Hamulyák, Marleen Zuurveld, Barbara A. Hutten, Peter E. Westerweel, Renske H. Olie, Hugo ten Cate, Marieke Kruip, Saskia Middeldorp, Karina Meijer, Michiel Coppens

    Get full text
    Article


  11. 11

    The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial by Fabio Efficace, Laura Cannella, Isabella Capodanno, Rosaria Sancetta, Veronica Porcu, Monia Lunghi, Annalisa Biagi, Fausto Castagnetti, Giovanni Caocci, Thomas Baldi, Roberto Marasca, Massimiliano Bonifacio, Massimiliano Bonifacio, Antonella Gozzini, Bruno Martino, Federica Sora, Peter E. Westerweel, Paola Fazi, Marco Vignetti, Fabrizio Pane, Massimo Breccia

    Published in Frontiers in Oncology (2025-08-01)
    Get full text
    Article


  12. 12

    Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study by Dina Nienke Lokhorst, Yolba Smit, Bart J.F. van den Bemt, Rosella P.M.G. Hermens, Marten R. Nijziel, Asiong K-S. Jie, Laura G.M. Daenen, Saskia K. Klein, Eduardus F.M. Posthuma, Peter E. Westerweel, Marjolein Donker, Mels Hoogendoorn, Charlotte L. Bekker, Nicole M.A. Blijlevens

    Published in Haematologica (2025-10-01)
    Get full text
    Article


  13. 13

    High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL by Paul J. Hengeveld, P. Martijn Kolijn, Jeroen A.A. Demmers, Wouter Doff, Julie M.N. Dubois, Melissa Rijken, Jorn L.J.C. Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten J. Gussinklo, Peter J.M. Valk, Laura M. Faber, Peter E. Westerweel, Arnon P. Kater, Mark-David Levin, Anton W. Langerak

    Published in HemaSphere (2023-10-01)
    Get full text
    Article


  14. 14

    Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia by Anne-Sophie Bouillon, Monica S. Ventura Ferreira, Shady Adnan Awad, Johan Richter, Andreas Hochhaus, Volker Kunzmann, Jolanta Dengler, Jeroen Janssen, Gert Ossenkoppele, Peter E. Westerweel, Peter A.W. te Boekhorst, Francois-Xavier Mahon, Henrik Hjorth-Hansen, Susanne Isfort, Thoas Fioretos, Sebastian Hummel, Mirle Schemionek, Stefan Wilop, Steffen Koschmieder, Susanne Saußele, Satu Mustjoki, Fabian Beier, Tim H. Brümmendorf

    Published in Blood Advances (2018-07-01)
    Get full text
    Article


  15. 15

    Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population by Camille C.B. Kockerols, Jeroen J.W.M Janssen, Nicole M.A. Blijlevens, Saskia K. Klein, Laura G.M. van Hussen-Daenen, Gwendolyn G.Y. van Gorkom, Willem M. Smit, Peter van Balen, Bart J. Biemond, Marjan J. Cruijsen, Maarten F. Corsten, Peter A.W. te Boekhorst, Harry R. Koene, Geerte L. van Sluis, Jan J. Cornelissen, Peter E. Westerweel

    Published in Haematologica (2022-09-01)
    Get full text
    Article


  16. 16

    Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study by Eva N. Hamulyák, Hanke M. G. Wiegers, Luuk J. J. Scheres, Barbara A. Hutten, Maria E. deLange, Anne Timmermans, Peter E. Westerweel, Marten R. Nijziel, Marieke J. H. A. Kruip, Marije ten Wolde, Paula F. Ypma, Frederikus A. Klok, Laurens Nieuwenhuizen, Sanne vanWissen, Marcel M. C. Hovens, Laura M. Faber, Pieter W. Kamphuisen, Harry R. Büller, Saskia Middeldorp

    Get full text
    Article


  17. 17

    Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients. by Abraham Rutgers, Peter E Westerweel, Bronno van der Holt, Simone Postma, Marit G A van Vonderen, Djura P Piersma, Douwe Postma, Maarten van den Berge, Eefje Jong, Marten de Vries, Leonie van der Burg, Dennis Huugen, Marjolein van der Poel, Linda M Kampschreur, Marcel Nijland, Jaap H Strijbos, Menno Tamminga, Pim G N J Mutsaers, Suzanne Schol-Gelok, Margriet Dijkstra-Tiekstra, Grigory Sidorenkov, Julien Vincenten, Wouter H van Geffen, Marjolein Knoester, Jos Kosterink, Reinold Gans, Coen Stegeman, Gerwin Huls, Tom van Meerten

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


Search Tools: